Roche and Eli Lilly are among major life science players in Indiana putting resources behind a public-private research institute that would discover and develop new health innovations. Industry leaders from the drugmakers, along with Biomet, Cook Medical, Dow AgroSciences and Indiana University Health have defined a set of common scientific interests that will be the […]
Biomet Inc. has made a $280 million binding offer to acquire the worldwide trauma business of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics Inc. “This transaction will provide Biomet with a much stronger presence in the global trauma market and greatly expands our sports, extremities and trauma business, which is a meaningful growth driver for […]
The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.
As the history of social legislation suggests -- and as this week's federal court ruling on the so-called individual mandate makes clear, the effects of healthcare reform on our politics may not be settled until a lot of President Obama's aides are collecting Medicare checks, according to the New York Times.
Synthes USA slapped a former sales rep and Biomet Inc. with a lawsuit accusing them of colluding to steal customers from the sales rep's Ohio territory. The suit alleges that John Scott of Dublin, Ohio, conspired with Biomet to solicit and convert Synthes customers before leaving Synthes' employ.
The Food & Drug Administration warned Biomet Inc. that its personalized knee implant planning offering, the Signature Personalized Patient Care system, lacks approval or clearance to be on the market in the United States.